France: Former Minister of Health Named in Serious Health Scandal

ER Editor: Buzyn started out as France’s health minister at the beginning of the ‘pandemic’, only to restrict public access to hydroxychloroquine around January 2020 while the political class and medical personnel were quietly using it according to reports from one of France’s well-known TV doctors, emergency physician Dr. Patrick Pelloux. Macron got her out of the way, to run as one of the candidates for mayor in Paris (she failed to get elected) as she was replaced by Olivier Veran during early 2020. Buzyn also added more vaccines to France’s childhood vaccination schedule. Naturally, she landed a cushy job affiliated with the WHO.

She famously cried at the podium in early 2020, declaring ‘we knew what was coming’ in relation to the virus. Her head may finally roll in a lawsuit emanating from this period, if not from the story below.


France: Agnès Buzyn, former Minister of Health, has been named in a serious health scandal


Agnès Buzyn, former Minister of Health, is cited in a serious health scandal. In September 2017, she had approved the marketing of the new formula of Levothyrox, a drug used by more than 3 million people in France to stabilize their TSH levels, a hormone that stimulates the thyroid. 4 years later, an expert report concludes that the new formula of the drug, manufactured by the laboratory Merck, had been approved by the National Agency for Safety and Medicines (ANSM) which was aware that it (the new formula) was very different from the first and that therefore it involved risks for consumers.

Agnès Buzyn is taking it easy in Geneva where she has been appointed French ambassador to the WHO. But the former Minister of Health, whose role in the management of the Coronavirus pandemic has been highly criticized, is cited in a serious case that doesn’t seem to interest the French press very much.

Indeed, in the last few days, a judicial expertise made public by a group of experts appointed by the Marseilles court has implicated the Merck laboratory and the French Medicines Agency for their role in the marketing of the new formula of Levothyrox, a drug used by more than 3 million people in France to stabilize their TSH level, a hormone that stimulates the thyroid.

The drug will eventually cause thousands of side effects in France. Yet, at the very beginning of its marketing, health authorities, including Agnès Buzyn, indicated that it posed no threat to the health of millions of consumers.

“There is no scandal. It is a crisis related to a lack of information and a lack of support, which must be understood. The new formula is even much more stable than the previous one,” said Agnès Buzyn, at the time Minister of Health, in September 2017.

Yet, a few years later, as revealed by the newspaper Le Monde, the expert report says quite the opposite. “Revealed by the site Les Jours, their expert report, which Le Monde was able to consult, lists a series of regulatory loopholes and serious failures of the Merck laboratory and health authorities, all of which could explain some of the adverse effects related to the change of formula,” informs Le Monde.

And to continue: “worse: according to the report, the National Agency for Drug Safety (ANSM) was aware, as early as September 2017, of a potential problem. The drug watchdog, however, did not take any corrective action, or even recognize, in the months following, the possible pharmacological origin of the disorders reported by patients.”

To learn more about this case, let’s look at the work of the media outlet Liberation, which explains everything:

“In 2017, while the old formula had been working for years, without causing side effects, the Merck laboratory put a new formula on the market. It changed what are called excipients, the substance(s) involved in the composition of a drug that are not the active ingredients. By choosing mannitol and citric acid instead of lactose… For the good of the patient, said Merck in unison with the Agency, both expressing the desire for a more stable product. Why not? But it would still have been necessary to carry out studies demonstrating the neutrality of these changes. However – and this is what the experts’ report confirms – this has not been done.”

Basically, everything was wrong. The new formula that was marketed in 2017 with the blessing of the ANSM and Buzyn; it was very different from the old formula. And even more seriously, in their report, the experts reveal a real scandal, that is, as early as September 2017, an ANSM expert recognized, in a note, that Levothyrox generics were not substitutable.

So there is no doubt that the idea that the new formula was substitutable was imposed. But by whom? This is the question to which no answer has yet been found. It should be remembered that thyroid patients have had to suffer the very difficult consequences of this change of formula. Among the side effects, there were depression, hair loss, memory loss, digestive disorders…

Will Agnès Buzyn be summoned by the French justice system to be held accountable? The probability of this happening is very low.




The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.